<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01521572</url>
  </required_header>
  <id_info>
    <org_study_id>2927/2011</org_study_id>
    <secondary_id>CEP2927/2011HUPE</secondary_id>
    <nct_id>NCT01521572</nct_id>
  </id_info>
  <brief_title>Effect of the Salbutamol on Mechanical Properties of Respiratory System</brief_title>
  <official_title>Effect of the Use of Salbutamol on the Mechanical Properties of the Respiratory System of Healthy Individuals, Smokers and COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rio de Janeiro State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rio de Janeiro State Research Supporting Foundation (FAPERJ)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rio de Janeiro State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the bronchodilator response of salbutamol on respiratory
      mechanics of healthy individuals, smokers and COPD with varying degrees of airway
      obstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical evaluation will be conducted and anthropometric measurements, then the pulmonary
      function tests: forced oscillation technique (FOT), whole body plethysmography, spirometry
      and-administration of salbutamol aerosol for assessment of bronchodilator response. After 20
      minutes, the individual will be evaluated again following the same sequence.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory function test</measure>
    <time_frame>two o'clock</time_frame>
    <description>Evaluation of pulmonary mechanics before and after salbutamol (short-acting bronchodilator) in healthy individuals, smokers and chronic obstructive pulmonary disease in stages: mild, moderate, severe and very severe according to GOLD criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Salbutamol</measure>
    <time_frame>twenty minutes</time_frame>
    <description>In the bronchodilator test will be used 400 micrograms of beta2-agonist short-acting. They will be asked to exhale slowly until they can no longer expel more air from the lungs. To place the inhaler with a spacer between the lips, pressing them well, but no bite. Shortly thereafter start to breathe through the mouth and will be released a jet of 100 micrograms of the bronchodilator. Then they will hold their breath for 10 seconds. 3 puffs are made with 1 minute interval between each application.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Smoking</condition>
  <condition>Airway Obstruction</condition>
  <arm_group>
    <arm_group_label>Salbutamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Short-acting bronchodilator for use in humans released by the Ministry of Health, widely used worldwide for the treatment of chronic obstructive pulmonary disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Salbutamol sulphate</intervention_name>
    <description>bronchodilator test, beta2-agonist, short-acting, six hours duration, 400 micrograms.</description>
    <arm_group_label>Salbutamol</arm_group_label>
    <other_name>Aerogold</other_name>
    <other_name>GO/DRUGS/341/L</other_name>
    <other_name>LOTE: YR1070</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals, smokers and patients with chronic obstructive pulmonary disease.

        Exclusion Criteria:

          -  healthy subjects: no history of smoking respiratory infection and disease respiratory

          -  smokers and chronic obstructive pulmonary disease patients: asthma and other
             respiratory diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerusa M Costa, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>State University of Rio de Janeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pedro L Melo, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Laboratory biomedical instrumentation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Agnaldo J Lopes, PhD</last_name>
    <phone>55+(21) 98536162</phone>
    <email>phel.lop@uol.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pedro L de Melo, PhD</last_name>
    <phone>55+(21) 2334-0705</phone>
    <email>plopes@uerj.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laboratory biomedical instrumentation - State University of Rio de Janeiro</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>20550013</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gerusa M Costa, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov</url>
    <description>http://www.ncbi.nlm.nih.gov/pubmed?term=gerusa%20maritimo%20da%20costa</description>
  </link>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2012</study_first_submitted>
  <study_first_submitted_qc>January 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2012</study_first_posted>
  <last_update_submitted>January 31, 2012</last_update_submitted>
  <last_update_submitted_qc>January 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rio de Janeiro State University</investigator_affiliation>
    <investigator_full_name>Gerusa Maritimo da Costa</investigator_full_name>
    <investigator_title>Master</investigator_title>
  </responsible_party>
  <keyword>chronic obstructive pulmonary disease,</keyword>
  <keyword>bronchial reversibility,</keyword>
  <keyword>bronchodilator,</keyword>
  <keyword>respiratory impedance,</keyword>
  <keyword>forced oscillation technique,</keyword>
  <keyword>plethysmography,</keyword>
  <keyword>spirometry</keyword>
  <keyword>Diagnostic Techniques, Respiratory System</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Airway Obstruction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albuterol</mesh_term>
    <mesh_term>Bronchodilator Agents</mesh_term>
    <mesh_term>Respiratory System Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

